Ftse Mib
36.471,75
0,12%
DAX
21.732,05
0,01%
S&P 500
6.040,53
-0,50%
NASDAQ
19.627,44
-0,28%
Bitcoin
101.960,14
-0,44%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Lifecore Biomedical Inc (LFCR) Lifecore Biomedical Inc (LFCR) Notizie

Lifecore Biomedical Inc

LFCR
5,94
-0,16 (-2,62%)
01 Feb 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
21/1/202523:16EDGAR2Form PRE 14A - Other preliminary proxy statements
17/1/202523:27EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
17/1/202523:27EDGAR2Form 8-K - Current report
17/1/202523:24GLOBELifecore Biomedical Announces Special Stockholder Meeting
07/1/202515:07EDGAR2Form 8-K - Current report
07/1/202515:00GLOBELifecore Biomedical Further Strengthens Financial Position..
06/1/202522:05GLOBELifecore Biomedical to Participate at 43rd Annual J.P...
02/1/202523:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/1/202522:15EDGAR2Form 8-K - Current report
02/1/202522:05GLOBELifecore Biomedical Reports Second Quarter Fiscal 2025..
26/12/202419:20EDGAR2Form SCHEDULE 13D/A - General Statement of Acquisition of..
19/12/202422:05GLOBELifecore Biomedical to Report Financial Results for Second..
19/12/202413:00GLOBELifecore Biomedical Selected by Nirsum Labs to Provide CDMO..
10/12/202422:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/12/202422:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/11/202423:29EDGAR2Form 8-K - Current report
26/11/202422:05GLOBELifecore Biomedical Amends and Extends Revolving Credit..
21/11/202422:17GLOBELifecore Biomedical Hosts Virtual Investor Day
21/11/202413:55EDGAR2Form 8-K - Current report
20/11/202416:14EDGAR2Form 144 - Report of proposed sale of securities
12/11/202422:05GLOBELifecore Biomedical to Present at Stephens Annual Investment..
12/11/202420:43EDGAR2Form 144 - Report of proposed sale of securities
08/11/202422:32EDGAR2Form 8-K - Current report
07/11/202413:00GLOBELifecore Biomedical to Host Virtual Investor Day Prior to..
04/11/202413:00GLOBELifecore Biomedical Appoints Thomas Guldager as Vice..
31/10/202421:18EDGAR2Form 144 - Report of proposed sale of securities
29/10/202421:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/10/202422:04EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
10/10/202422:40EDGAR2Form S-8 - Securities to be offered to employees in employee..
10/10/202422:38EDGAR2Form S-8 - Securities to be offered to employees in employee..
10/10/202422:37EDGAR2Form S-1 - General form for registration of securities under..
10/10/202422:36EDGAR2Form POS AM - Post-Effective amendments for registration..
07/10/202419:03EDGAR2Form 144 - Report of proposed sale of securities
04/10/202413:41EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
04/10/202413:36EDGAR2Form 8-K - Current report
04/10/202413:30GLOBELifecore Biomedical Reports First Quarter of Fiscal 2025..
04/10/202413:20GLOBELifecore Biomedical Raises $24.3 Million in Private..
03/10/202422:05GLOBELifecore Biomedical to Report Financial Results for First..
01/10/202413:00GLOBELifecore Biomedical Selected by Lindy Biosciences to Support..
25/9/202422:05GLOBELifecore Biomedical to Participate at Upcoming Industry..
23/9/202422:21EDGAR2Form DEF 14A - Other definitive proxy statements
23/9/202422:14EDGAR2Form 8-K - Current report
20/9/202422:00EDGAR2Form 144 - Report of proposed sale of securities
19/9/202413:00GLOBELifecore Biomedical Announces High-Speed, Multi-Purpose..
12/9/202422:05GLOBELifecore Biomedical to Participate in Craig-Hallum..
12/9/202413:09EDGAR2Form 8-K - Current report
12/9/202413:00GLOBELifecore Biomedical Regains Compliance with Nasdaq Listing..
10/9/202413:00GLOBELifecore Biomedical Appoints Brikkelle Thompson as Senior..
06/9/202422:05GLOBELifecore Biomedical Announces Inducement Grants Under Nasdaq..
05/9/202422:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 6,07 Min: 5,87 Max: 6,11
Chiusura: 6,10

La tua Cronologia

NASDAQ
LFCR
Lifecore Biomedical
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci